Cambridge Investment Research Advisors, Inc.
Position in LH — Labcorp Holdings Inc.
CIK 1419186
FAIRFIELD, IA
Position in LH
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$3,082,455
+$303,709 QoQ
Shares Held
11,553
+4.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $50,450,681 across 18 Diagnostics & Research names. LH ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
42,745 | $21,010,449 | |
| 2 | DHR |
Danaher Corp /De/
|
34,195 | $6,483,372 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
33,015 | $5,630,378 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
11,553 | $3,082,455 | |
| 5 | DGX |
Quest Diagnostics Inc
|
14,494 | $2,840,534 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4,546 | $2,554,351 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
3,663 | $1,758,935 | |
| 8 | A |
Agilent Technologies, Inc.
|
13,432 | $1,530,979 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,082,455 | 11,553 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,778,746 | 11,076 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,994,896 | 10,433 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,707,528 | 10,314 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,344,855 | 10,075 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,289,301 | 9,983 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,991,877 | 8,913 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,710,094 | 8,403 | Shares | Sole | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||